RHYTHM PHARMACEUTICALS, INC. (RYTM) Total liabilities 2016–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) total liabilities at each fiscal year-end, per SEC filings.
$210.2MFY2025 · since FY2016: $5.0M → $210.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $210.2M | -7.7% |
| FY2024 | $227.7M | +39.7% |
| FY2023 | $163.0M | +37.9% |
| FY2022 | $118.2M | +160.6% |
| FY2021 | $45.4M | +120.8% |
| FY2020 | $20.5M | -25.3% |
| FY2019 | $27.5M | +97.1% |
| FY2018 | $14.0M | +100.8% |
| FY2017 | $6.9M | +37.8% |
| FY2016 | $5.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice